http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-093668-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_981a37900e6991fb373304ed2ba5a703 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N37-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-653 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N37-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N55-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N59-20 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N47-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N37-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-653 |
| filingDate | 2013-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bfb06f0f18879c7e940d2e30ec93d4e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4250e022422d4410c0659c8bd0a71501 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e4a3aaaa811038b51bb3f5ec9ec9c73 |
| publicationDate | 2015-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-093668-A1 |
| titleOfInvention | TERNARY FUNGICIDE BLENDS |
| abstract | Claim 1: A composition, comprising (i) at least one compound of the general formula (1) wherein R¹ represents a hydrogen atom or a methyl group and R² represents a methyl group, a difluoromethyl group or a trifluoromethyl group; and (ii) at least two compounds (II) and (III) selected from groups A to D: (A) the carboxamide group; (B) the group of azoles; (C) the group of inhibitors of the respiratory chain complex III; and (D) the group of those with different modes of action, with the proviso that the specified compounds (II) and (III) belong to different groups (A) to (D). Claim 2: A composition according to claim 1, wherein the compound of the general formula (1) is represented by one of the compounds (2) to (6). Claim 3: Composition according to claim 1 or 2, wherein the compound of the group (A) of carboxamides is selected from (1.1) bixafen (581809-46-3), (1.2) boscalid (188425-85-6), (1.3) carboxine (5234-68-4), (1.4) diflumetorim (130339-07-0), (1.5) fenfuram (24691-80-3), (1.6) fluopiram (658066-35-4), (1.7 ) flutolanyl (66332-96-5), (1.8) fluxapiroxad (907204-31-3), (1.9) furametpir (123572-88-3), (1.10) furmecyclox (60568-05-0), (1.11) isopirazam (mixture of 1RS, 4SR, 9RS syn-epimeric racemate and 1RS, 4SR, 9SR anti-epimeric racemate) (881685-58-1), (1.12) isopirazam (1RS, 4SR, 9SR anti-epimeric racemate), (1.13) isopirazam (anti-epimeric enantiomer 1R, 4S, 9S) (683777-14-2), (1.14) isopirazam (anti-epimeric enantiomer 1S, 4R, 9R) (1130207-91-8), (1.15) isopirazam (racemate syn -epimeric 1RS, 4SR, 9RS), (1.16) isopirazam (syn-epimeric racemate 1R, 4S, 9R) (1240879-17-7), (1.17) isopirazam (syn-epimeric racemate 1S, 4R, 9S) (1130207- 94-1), (1.18) mepronyl (5581 4-41-0), (1.19) oxycarboxine (5259-88-1), (1.20) penflufen (494793-67-8), (1.21) pentiopirad (183675-82-3), (1.22) sedaxane (874967- 67-6), (1.23) tifluzamide (130000-40-7), (1.24) 1-methyl-N- [2- (1,1,2,2-tetrafluoroethoxy) phenyl] -3- (trifluoromethyl) -1H -pyrazol-4-carboxamide (923953-99-5), (1.25) 3- (difluoromethyl) -1-methyl-N- [2- (1,1,2,2-tetrafluoroethoxy) phenyl] -1H-pyrazole- 4-carboxamide (923953-98-4), (1.26) 3- (difluoromethyl) -N- [4-fluoro-2- (1,1,2,3,3,3-hexafluoropropoxy) phenyl] -1-methyl -1H-pyrazol-4-carboxamide (1172611-40-3), (1.27) N- [1- (2,4-dichlorophenyl) -1-methoxypropan-2-yl] -3- (difluoromethyl) -1-methyl -1H-pyrazol-4-carboxamide (1092400-95-7), (1.28) 5,8-difluoro-N- [2- (2-fluoro-4 - {[4- (trifluoromethyl) pyridin-2-yl] oxy} phenyl) ethyl] quinazolin-4-amine (1210070-84-0), (1.29) benzovindiflupir (1072957-71-1), (1.30) N - [(1S, 4R) -9- (dichloromethylene) -1 , 2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl] -3- (difluoromethyl) -1-methyl-1H-pyrazol-4-carboxamide, (1.31) N - [(1R, 4S) - 9- (dichloromethylene) -1,2,3,4-tetrahydro-1,4-meta nonaphthalen-5-yl] -3- (difluoromethyl) -1-methyl-1H-pyrazol-4-carboxamide. Claim 4: Composition according to any one of claims 1 to 3, wherein the compound of the group (B) of azoles is selected from (2.1) bitertanol (55179-31-2), (2.2) bromuconazole (116255-48-2 ), (2.3) ciproconazole (113096-99-4), (2.4) diphenoconazole (119446-68-3), (2.5) diniconazole (83657-24-3), (2.6) diniconazole-M (83657-18-5 ), (2.7) epoxiconazole (106325-08-0), (2.8) etaconazole (60207-93-4), (2.9) fenbuconazole (114369-43-6), (2.10) fenhexamid (126833-17-8), (2.11) fluquinconazole (136426-54-5), (2.12) flusilazol (85509-19-9), (2.13) flutriafol (76674-21-0), (2.14) hexaconazole (79983-71-4), (2.15 ) imazalil (35554-44-0), (2.16) imazalil sulfate (58594-72-2), (2.17) ipconazole (125225-28-7), (2.18) metconazole (125116-23-6), (2.19 ) miclobutanyl (88671-89-0), (2.20) penconazole (66246-88-6), (2.21) prochloraz (67747-09-5), (2.22) propiconazole (60207-90-1), (2.23) protioconazole (178928-70-6), (2.24) pinbuticarb (88678-67-5), (2.25) pinfenox (88283-41-4), (2.26) quinc onazol (103970-75-8), (2.27) simeconazole (149508-90-7), (2.28) spiroxamine (118134-30-8), (2.29) tebuconazole (107534-96-3), (2.30) tetraconazole ( 112281-77-3), (2.31) triadimephone (43121-43-3), (2.32) triadimenol (55219-65-3), (2.33) triflumizol (68694-11-1), (2.34) triforin (26644- 46-2) and (2.35) triticonazole (131983-72-7). Claim 5: Composition according to any one of claims 1 to 4, wherein the compound of the group (C) of respiratory chain complex III inhibitors is selected from (3.1) ametoctradin (865318-97-4), (3.2) azoxystrobin (131860-33-8), (3.3) ciazofamid (120116-88-3), (3.4) dimoxystrobin (141600-52-4), (3.5) enoxastrobin (238410-11-2), (3.6) famoxadone ( 131807-57-3), (3.7) phenamidone (161326-34-7), (3.8) flufenoxystrobin (918162-02-4), (3.9) fluoxastrobin (361377-29-9), (3.10) kresoxim-methyl ( 143390-89-0), (3.11) metominostrobin (133408-50-1), (3.12) orisastrobin (189892-69-1), (3.13) picoxystrobin (117428-22-5), (3.14) pyraclostrobin (175013- 18-0), (3.15) trifloxystrobin (141517-21-7), and (3.16) N-methyl-a-methoxyimino-2 - [(2,5-dimethylphenoxy) methyl] phenylacetamide. Claim 6: Composition according to any one of claims 1 to 5, wherein the compound of the group (D) of fungicides with different modes of action is selected from (4.1) captan (133-06-2), (4.2) chlorothalonyl ( 1897-45-6), (4.3) copper hydroxide (20427-59-2), (4.4) copper naphthenate (1338-02-9), (4.5) copper oxide (1317-39-1), ( 4.6) copper oxychloride (1332-40-7), (4.7) copper sulfate (²⁺) (7758-98-7), (4.8) dithianone (3347-22-6), (4.9) dodine (2439- 10-3), (4.10) free base dodine (112-65-2), (4.11) ferbam (14484-64-1), (4.12) fluorofolpet (719-96-0), (4.13) folpet (133- 07-3), (4.14) guazathine (108173-90-6), (4.15) guazathine acetate (69311-74-6), (4.16) iminoctadine (13516-27-3), (4.17) iminoctadine albesylate ( 169202-06-6), (4.18) iminoctadine triacetate (57520-17-9), (4.19) manganese-copper (53988-93-5), (4.20) mancozeb (8018-01-7), (4.21) maneb (12427-38-2), (4.22) metiram (9006-42-2), (4.23) metiram zinc (9006-42-2), (4.24) oxine-copper ( 10380-28-6), (4.25) propamidine (104-32-5), (4.26) propineb (12071-83-9), (4.27) tiram (137-26-8), (4.28) zineb (12122- 67-7), (4.29) ziram (137-30-4), (4.30) anilazine (101-05-3), and (4.31) 2,6-dimethyl-1H, 5H- [1,4] dithiino [ 2,3-c: 5,6-c] dipyrrol-1,3,5,7 (2H, 6H) -tetrone (16114-35-5), (4.32) metalaxyl (57837-19-1), (4.33 ) metalaxyl-M (mefenoxam) (70630-17-0), (4.34) fludioxonyl (131341-86-1). Claim 12: A control method for harmful microorganisms, comprising contacting said harmful microorganisms or their habitat with a composition according to any of claims 1 to 10. Claim 13: A seed treatment procedure, comprising contacting said seeds with a composition according to any one of claims 1 to 10. Claim 15: A seed treated with a composition according to any one of claims 1 to 10. |
| priorityDate | 2012-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 193.